PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma

BACKGROUND: PD-L1 expression levels determined by immunostaining are known to be related to the survival rate and prognosis of patients with various types of cancers, as well as to the therapeutic response to immune checkpoint inhibitors. Recently, the U.S. Food and Drug Administration approved an i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ki Hyung, Choi, Kyung Un, Kim, Ahrong, Lee, So Jung, Lee, Jung Hee, Suh, Dong Soo, Kwon, Byung-su, Hwang, Chungsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580633/
https://www.ncbi.nlm.nih.gov/pubmed/31208449
http://dx.doi.org/10.1186/s13048-019-0526-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580633/
https://www.ncbi.nlm.nih.gov/pubmed/31208449
http://dx.doi.org/10.1186/s13048-019-0526-0

Ejemplares similares